Lugpit, Shebrie .

HRN: 23-89-45  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2025
CEFUROXIME 750MG (VIAL)
06/10/2025
06/17/2025
IV
285mg
Q8h
PCAP
Checking Initial Appropriateness 
06/11/2025
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
06/11/2025
06/15/2025
ORAL
2.5ml
OD
Pneumonia
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: